Stephen Graziano, MD
CURRENT APPOINTMENTS
Professor of Medicine
Division Chief of Hematology and Oncology
Division Chief of Upstate Cancer Center Adult Hematology/Oncology
Division Chief of Medicine
SPECIALTIES
Internal Medicine
Oncology
Hematology
Medical Oncology
LANGUAGES
English
PATIENT TYPE
Adults
CLINICAL BACKGROUND AND MY APPROACH TO CARE
Lung cancer and Thoracic Malignancies
Prognostic Factors in Patients with Non-Small Cell Lung Cancer; lung cancer clinical trials; participation in the Alliance for Clinical Trials in Oncology.
CLINICAL TRIALS
EA5182: Randomized Phase III Study of Combination Osimertinib (AZD9291) and Bevacizumab versus Osimertinib (AZD9291) Alone as First-Line Treatment for Patients with Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)
Read more
Read more
849-012: A Randomized Phase 3 Study of MRTX849 versus Docetaxel in Patients with Previously Treated Non-Small Cell Lung Cancer with KRAS G12C Mutation
Read more
Read more
AFT-46 CHIO3 Trial: CHemotherapy Combined with Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer
Read more
Read more
A081801-Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO
Read more
Read more
EA5181: Randomized Phase III Trial of MEDI4736 (Durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable Stage 3 NSCLC
Read more
Read more
S1701 - A Randomized Phase II Trial of Carboplatin-Paclitaxel with or without Ramucirumab in Patients with Unresectable Locally Advanced, Recurrent, or Metastatic Thymic Carcinoma
Read more
Read more
EA5163/S1709 INSIGNA: A Randomized, Phase III Study of Firstline Immunotherapy
alone or in Combination with Chemotherapy in Induction/Maintenance or Postprogression in Advanced
Nonsquamous NonSmall Cell Lung Cancer (NSCLC) with Immunobiomarker SIGNature driven Analysis
Read more
Read more
Alliance A151216 - Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Read more
Read more
ECOG E4512 - A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
Read more
Read more
DISEASES & CONDITIONS TREATED
All Cancers and Hematological Conditions
Lung Cancer
Mesothelioma
TREATMENTS / SERVICES
Apheresis
Blood Transfusion
Bone Marrow Aspiration
Bone Marrow Biopsy
Bone Marrow Transplantation (BMT)
Chemotherapy
Clinical Trials
Conscious Sedation
Infusional Therapies
Lumbar Puncture
Paracentesis
Stem Cell Collection Procedures
Stem Cell Transplantation
Thoracentesis
CLINICAL LOCATIONS
Upstate University Hospital
750 East Adams Street
Syracuse, NY 13210
315 464-5540
Upstate Cancer Center
750 East Adams Street
Syracuse, NY 13210
315 464-8200
603 Seneca Street
603 Seneca Street
Oneida, NY 13421
315 361-1041
CLINICAL SECTION AFFILIATIONS
Medicine
Hematology and Oncology
Upstate Cancer Center
Medical Oncology
CURRENT HOSPITAL PRIVILEGES
Upstate University Hospital
CAMPUSES
Downtown